Back to search

Article

Antidepressant switching as a proxy phenotype for drug non-response: investigating clinical, demographic and genetic characteristics

2024-11-10

Abstract excerpt

<h4>Background</h4> Selective serotonin reuptake inhibitors (SSRIs) are a first-line pharmacological therapy in major depressive disorder (MDD), but treatment response rates are low. Clinical trials lack the power to study the genetic contribution to SSRI response. Real-world evidence from electronic health records provides larger sample sizes, but novel response definitions are needed to accurately define SSRI no...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
192bd4d6-59c5-5470-bb1d-376c13dc3611
DOI
10.1101/2024.11.09.24316987
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antidepressant switching as a proxy phenotype for drug non-response: investigating clinical, demographic and genetic characteristicsDOI 10.1101/2024.11.09.24316987
Select a neighboring publication to make it the new centre.